Ledger.Open graph →
SEC Form D · filed August 31, 2020

AEON Biopharma, Inc

Offering
$25.0M
Sold
$25.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEWPORT BEACH, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Charles Hultman · McLean, VADirectorDonald Lacey · NEW YORK, NYDirectorScott Akamine · Newport Beach, CAExecRobert E. Davis · Cranberry Twp., PAExecJost Fischer · Newport Beach, CADirectorGary P. Bechtel · Grand Rapids, MIDirectorMarc Forth · Newport Beach, CAExecStuart M. Shroyer · Cincinnati, OHExecJamie Magyera · NEW YORK, NYExecMichael B. Robinson · Grand Cayman, Cayman IslandsDirectorJohn B. Robertshaw · NEW YORK, NYExecBrian D. Johnson · La Porte, INExecMichael E. Edleson · Grand Cayman, Cayman IslandsDirectorTodd B. Myers · NEW YORK, NYExecTimothy Sweeting · Grand Cayman, Cayman IslandsDirectorSimone Blank · Newport Beach, CADirectorRobert Grant · Newport Beach, CADirectorVikram Malik · Newport Beach, CADirectorRichard Taketa · Newport Beach, CADirectorTodd Groome · Grand Cayman, Cayman IslandsDirectorDavid Z. Chang · Cumming, GADirectorLee Ann D. Hartinger · Cincinnati, OHDirectorChris Carr · Newport Beach, CAExecDarren O'Brien · Newport Beach, CADirectorBenjamin D. Rankin · Birmingham, ALDirectorTom B. Fortin · NEW YORK, NYDirectorRichard Taketa · Newport Beach, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗